Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines Janet SultanaPaola Maria CutroneoGianluca Trifirò Current Opinion 21 July 2020 Pages: 691 - 698
The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance Marco TuccoriIrma ConvertinoCorrado Blandizzi Leading Article 22 June 2020 Pages: 699 - 709
Critical Assessment of Pharmacokinetic Drug–Drug Interaction Potential of Tofacitinib, Baricitinib and Upadacitinib, the Three Approved Janus Kinase Inhibitors for Rheumatoid Arthritis Treatment Vijayabhaskar VeeravalliRanjeet P. DashNuggehally R. Srinivas Review Article 04 May 2020 Pages: 711 - 725
Effect of Bempedoic Acid on Serum Uric Acid and Related Outcomes: A Systematic Review and Meta-analysis of the available Phase 2 and Phase 3 Clinical Studies Arrigo F. G. CiceroRoberto PontremoliClaudio Borghi Systematic Review 01 May 2020 Pages: 727 - 736
Oxycodone, Hydromorphone, and the Risk of Suicide: A Retrospective Population-Based Case–Control Study Graham MazereeuwTara GomesDavid N. Juurlink Original Research Article 23 April 2020 Pages: 737 - 743
Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands Linda HärmarkGerda WeitsFlorence van Hunsel Original Research Article Open access 16 May 2020 Pages: 745 - 749
Safety Profile of Ceftazidime–Avibactam: Pooled Data from the Adult Phase II and Phase III Clinical Trial Programme Karen ChengPaul NewellAngela Wardman Original Research Article Open access 29 June 2020 Pages: 751 - 766
DPP-4 Inhibitors in Combination with Lipid-Lowering Agents and Risk of Serious Muscular Injury: A Nested Case-Control Study in a Nationwide Cohort of Patients with Type 2 Diabetes Mellitus Antoine ParienteVanessa LabatJulien Bezin Original Research Article 18 April 2020 Pages: 767 - 774
A Feasibility Study of Drug–Drug Interaction Signal Detection in Regular Pharmacovigilance Sara HultDaniele SartoriG. Niklas Norén Original Research Article Open access 17 July 2020 Pages: 775 - 785
Detecting Medicine Safety Signals Using Prescription Sequence Symmetry Analysis of a National Prescribing Data Set Clare E. KingNicole L. PrattEirene C. Behm Original Research Article 23 June 2020 Pages: 787 - 795
Prospective Evaluation of Adverse Event Recognition Systems in Twitter: Results from the Web-RADR Project Lucie M. GattepailleSara Hedfors VidlinJohan Ellenius Original Research Article Open access 14 May 2020 Pages: 797 - 808
Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment Vicki OsborneMiranda DaviesSaad Shakir Original Research Article Open access 23 June 2020 Pages: 809 - 821
Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands Linda HärmarkGerda WeitsFlorence van Hunsel Correction Open access 02 July 2020 Pages: 823 - 823
Correction to: Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS) Taylor M. PatekChengwen TengChristopher R. Frei Correction 26 June 2020 Pages: 825 - 825
Correction to: Safety Communication Tools and Healthcare Professionals’ Awareness of Specific Drug Safety Issues in Europe: A Survey Study Sieta T. de VriesMaartje J. M. van der Saron behalf of SCOPE work package 6 Correction 30 June 2020 Pages: 827 - 829